Mammary Neoplasms, Experimental
"Mammary Neoplasms, Experimental" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Experimentally induced mammary neoplasms in animals to provide a model for studying human BREAST NEOPLASMS.
MeSH Number(s)
C04.588.531.500
C04.619.590
E05.598.500.496.843
Concept/Terms
Mammary Neoplasms, Experimental- Mammary Neoplasms, Experimental
- Experimental Mammary Neoplasm
- Mammary Neoplasm, Experimental
- Neoplasm, Experimental Mammary
- Neoplasms, Experimental Mammary
- Experimental Mammary Neoplasms
Below are MeSH descriptors whose meaning is more general than "Mammary Neoplasms, Experimental".
Below are MeSH descriptors whose meaning is more specific than "Mammary Neoplasms, Experimental".
This graph shows the total number of publications written about "Mammary Neoplasms, Experimental" by people in Harvard Catalyst Profiles by year, and whether "Mammary Neoplasms, Experimental" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 2 | 4 | 6 |
| 1994 | 6 | 5 | 11 |
| 1995 | 8 | 4 | 12 |
| 1996 | 7 | 3 | 10 |
| 1997 | 4 | 1 | 5 |
| 1998 | 3 | 2 | 5 |
| 1999 | 5 | 2 | 7 |
| 2000 | 8 | 3 | 11 |
| 2001 | 6 | 3 | 9 |
| 2002 | 12 | 4 | 16 |
| 2003 | 6 | 4 | 10 |
| 2004 | 8 | 3 | 11 |
| 2005 | 10 | 2 | 12 |
| 2006 | 11 | 2 | 13 |
| 2007 | 5 | 2 | 7 |
| 2008 | 3 | 1 | 4 |
| 2009 | 7 | 4 | 11 |
| 2010 | 10 | 1 | 11 |
| 2011 | 14 | 3 | 17 |
| 2012 | 10 | 3 | 13 |
| 2013 | 12 | 5 | 17 |
| 2014 | 7 | 4 | 11 |
| 2015 | 10 | 3 | 13 |
| 2016 | 8 | 8 | 16 |
| 2017 | 5 | 3 | 8 |
| 2018 | 5 | 2 | 7 |
| 2019 | 6 | 3 | 9 |
| 2020 | 5 | 0 | 5 |
| 2021 | 5 | 3 | 8 |
| 2022 | 2 | 0 | 2 |
Below are the most recent publications written about "Mammary Neoplasms, Experimental" by people in Profiles.
-
Escape from breast tumor dormancy: The convergence of obesity and menopause. Proc Natl Acad Sci U S A. 2022 10 11; 119(41):e2204758119.
-
Canagliflozin interrupts mTOR-mediated inflammatory signaling and attenuates DMBA-induced mammary cell carcinoma in rats. Biomed Pharmacother. 2022 Nov; 155:113675.
-
WWP1 inactivation enhances efficacy of PI3K inhibitors while suppressing their toxicities in breast cancer models. J Clin Invest. 2021 12 15; 131(24).
-
Anti-breast cancer action of carbonic anhydrase IX inhibitor 4-[4-(4-Benzo[1,3]dioxol-5-ylmethyl-piperazin-1-yl)-benzylidene-hydrazinocarbonyl]-benzenesulfonamide (BSM-0004): in vitro and in vivo studies. J Enzyme Inhib Med Chem. 2021 Dec; 36(1):954-963.
-
The adaptive immune system is a major driver of selection for tumor suppressor gene inactivation. Science. 2021 Sep 17; 373(6561):1327-1335.
-
Comparing syngeneic and autochthonous models of breast cancer to identify tumor immune components that correlate with response to immunotherapy in breast cancer. Breast Cancer Res. 2021 08 05; 23(1):83.
-
Let-7f miRNA regulates SDF-1a- and hypoxia-promoted migration of mesenchymal stem cells and attenuates mammary tumor growth upon exosomal release. Cell Death Dis. 2021 05 20; 12(6):516.
-
Combining losartan with radiotherapy increases tumor control and inhibits lung metastases from a HER2/neu-positive orthotopic breast cancer model. Radiat Oncol. 2021 Mar 04; 16(1):48.
-
Immunotherapy for breast cancer using EpCAM aptamer tumor-targeted gene knockdown. Proc Natl Acad Sci U S A. 2021 03 02; 118(9).
-
Oncogenic Ras Disrupts Epithelial Integrity by Activating the Transmembrane Serine Protease Hepsin. Cancer Res. 2021 03 15; 81(6):1513-1527.